CoChat
Sign Up
Cited by 28Bacterial Identification and Susceptibility TestingSepsis Diagnosis and TreatmentAntibiotic Use and Resistance

Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia

Open access
Babowicz, Faith, LaPlante, Reid, Mitchell, Colby, O’Donnell, J. Nicholas, Tobin, Ellis, George, Mary, Carreno, Joseph J.·2021·Antimicrobial Agents and Chemotherapy
DOI 10.1128/aac.02364-20PMC PMC8315910
Open this paper in CoChat — free account

Abstract

The Accelerate Pheno and BacT/Alert Virtuo systems may improve bacteremia management. Here, we evaluated the impact of both devices on outcomes in patients with sepsis and concurrent Gram-negative bacteremia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.02364-20

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Improvements in TAT and faster treatment adaptation have been attributed to better outcomes in patients with BSI, including improved survival rates in some studies.

    “While the exact cause of this finding cannot be determined due to the observational nature of the study, improvements in TAT and faster treatment adaptation have been attributed to better outcomes in patients with BSI, including improved survival rates in some studies [23–25].”

    From Lab efficiency and improvements in the management of bloodstream infections: a before and after study (2025) · cites this paper as [23]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 36

  1. [1]1. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M, Sepsis De fi nitions Task Force. 2016. Developing a new de fi nition and assessing new clinical criteria for septic shock: for the Third International Consensus De fi nitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:775 -787. https://doi.org/10.1001/ jama.2016.0289.
  2. [2]2. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. 2013. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165 -228. https://doi.org/10.1007/s00134-012-2769-8. · DOI
  3. [3]3. Howell MD, Davis AM. 2017. Management of sepsis and septic shock. JAMA 317:847 -848. https://doi.org/10.1001/jama.2017.0131. · DOI
  4. [4]4. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2005. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760 -766. https://doi.org/10.1128/AAC.49.2.760-766.2005. · DOI
  5. [5]5. Lueangarun S, Leelarasamee A. 2012. Impact of inappropriate empiric antimicrobial therapy on mortality of septic patients with bacteremia: a retrospective study. Interdiscip Perspect Infect Dis 2012:765205. https:// doi.org/10.1155/2012/765205. · DOI
  6. [6]6. Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M, CDC Prevention Epicenters Program. 2020. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3:e202899. https://doi.org/10.1001/jamanetworkopen .2020.2899. · DOI
  7. [7]7. Cizman M, Plankar Srovin T. 2018. Antibiotic consumption and resistance of gram-negative pathogens (collateral damage). GMS Infect Dis 6:Doc05. https://doi.org/10.3205/id000040. · DOI
  8. [8]8. Brown KA, Khanafer N, Daneman N, Fisman DN. 2013. Meta-analysis of antibiotics and the risk of community-associated Clostridium dif fi cile infection. Antimicrob Agents Chemother 57:2326 -2332. https://doi.org/ 10.1128/AAC.02176-12. · DOI
  9. [9]9. Bauer KA, Perez KK, Forrest GN, Goff DA. 2014. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis 59 (Suppl 3):S134 -S145. https://doi.org/10.1093/cid/ciu547. · DOI
  10. [10]10. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identi fi cation via matrixassisted laser desorption/ionization time-of- fl ight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237 -1245. https://doi.org/10.1093/ cid/cit498.
  11. [11]11. Frye AM, Baker CA, Rustvold DL, Heath KA, Hunt J, Leggett JE, Oethinger M. 2012. Clinical impact of a real-time PCR assay for rapid identi fi cation of staphylococcal bacteremia. J Clin Microbiol 50:127 -133. https://doi.org/ 10.1128/JCM.06169-11. · DOI
  12. [12]12. Carreno JJ, Lomaestro BM, Jacobs AL, Meyer RE, Evans A, Montero CI. 2016. Assessment of time to clinical response in patients with sepsis treated before and after implementation of a matrix-assisted laser desorption ionization time-of- fl ight blood culture identi fi cation algorithm. Infect Control Hosp Epidemiol 37:916 -923. https://doi.org/10.1017/ice .2016.105. · DOI
  13. [13]13. Dare RK, Lusardi K, Pearson C, McCain KD, Daniels B, Van S, Rico JC, Painter J, Lakkad M, Rosenbaum ER, Bariola JR. 2020. Clinical impact of Accelerate Pheno rapid blood culture detection system in bacteremic patients. Clin Infect Dis https://doi.org/10.1093/cid/ciaa649. · DOI
  14. [14]14. Sheth S, Miller M, Prouse AB, Baker S. 2020. Pharmacist-driven implementation of fast identi fi cation and antimicrobial susceptibility testing improves outcomes for patients with Gram-negative bacteremia and candidemia. Antimicrob Agents Chemother 64:e00578-20. https://doi.org/10 .1128/AAC.00578-20.
  15. [15]15. Banerjee R, Komarow L, Virk A, Rajapakse N, Schuetz AN, Dylla B, Earley M, Lok J, Kohner P, Ihde S, Cole N, Hines L, Reed K, Garner OB, Chandrasekaran S, de St Maurice A, Kanatani M, Curello J, Arias R, Swearingen W, Doernberg SB, Patel R, Antibacterial Resistance Leadership Group. 2020. Randomized trial evaluating clinical impact of RAPid IDenti fi cation and Susceptibility testing for Gram Negative bacteremia (RAPIDS-GN). Clin Infect Dis https://doi.org/10.1093/cid/ciaa528. · DOI · Paper page
  16. [16]16. Ly T, Gulia J, Pyrgos V, Waga M, Shoham S. 2008. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 4:637 -640. https://doi.org/10.2147/tcrm.s2838. · DOI
  17. [17]17. Wong JR, Bauer KA, Mangino JE, Goff DA. 2012. Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother 46:1484 -1490. https://doi.org/10.1345/aph.1R439. · DOI
  18. [18]18. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. 2010. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 51:1074 -1080. https://doi.org/10.1086/656623. · DOI
  19. [19]19. Carreno JJ, Eaton R, Itro L, Babowicz F, Falvo J, Tobin E, Mitchell C, George M. 2019. Time to clinical response in sepsis associated with an algorithm for blood-culture pathogen identi fi cation using matrix-assisted laser desorption ionization time-of- fl ight mass spectroscopy. Am J Health Syst Pharm 76:460 -469. https://doi.org/10.1093/ajhp/zxy087. · DOI
  20. [20]20. Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL. 2017. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis 64:15 -23. https://doi.org/10.1093/cid/ciw649. · DOI
  21. [21]21. Yee R, Dien Bard J, Simner PJ. 2021. The genotype to phenotype dilemma: how should laboratories approach discordant susceptibility results? J Clin Microbiol 59:e00138-20. https://doi.org/10.1128/JCM.00138-20. · DOI
  22. [22]22. Tamma PD, Sharara SL, Pana ZD, Amoah J, Fisher SL, Tekle T, Doi Y, Simner PJ. 2019. Molecular epidemiology of ceftriaxone non-susceptible Enterobacterales isolates in an academic medical center in the United States. Open Forum Infect Dis 6:ofz353. https://doi.org/10.1093/o fi d/ofz353. · DOI
  23. [23]23. Shi X, Kadiyala U, VanEpps JS, Yau ST. 2018. Culture-free bacterial detection and identi fi cation from blood with rapid, phenotypic, antibiotic susceptibility testing. Sci Rep 8:3416. https://doi.org/10.1038/s41598-018 -21520-9. · DOI
  24. [24]24. Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S. 2017. Evaluation of the Accelerate Pheno system for fast identi fi cation and antimicrobial susceptibility testing from positive blood cultures in bloodstream infections caused by Gram-negative pathogens. J Clin Microbiol 55:2116 -2126. https://doi.org/10.1128/JCM.00181-17. · DOI
  25. [25]25. Burnham JP, Wallace MA, Fuller BM, Shupe A, Burnham CD, Kollef MH. 2019. Clinical effect of expedited pathogen identi fi cation and susceptibility testing for Gram-negative bacteremia and candidemia by use of the Accelerate Pheno system. J Appl Lab Med 3:569 -579. https://doi.org/10 .1373/jalm.2018.027201.
  26. [26]26. Le Guern R, Titecat M, Loiez C, Duployez C, Wallet F, Dessein R. 2021. Comparison of time-to-positivity between two blood culture systems: a detailed analysis down to the genus-level. Eur J Clin Microbiol Infect Dis https://doi.org/10.1007/s10096-021-04175-9. · DOI
  27. [27]27. Kim SC, Lee S, Kim S, Cho OH, Park H, Yu SM. 2019. Comparison of clinical performance between BacT/Alert Virtuo and BacT/Alert 3D blood culture systems. Ann Lab Med 39:278 -283. https://doi.org/10.3343/alm.2019.39.3.278. · DOI
  28. [28]28. Ehren K, Meissner A, Jazmati N, Wille J, Jung N, Vehreschild JJ, Hellmich M, Seifert H. 2020. Clinical impact of rapid species identi fi cation from positive blood cultures with same-day phenotypic antimicrobial susceptibility testing on the management and outcome of bloodstream infections. Clin Infect Dis 70:1285 -1293. https://doi.org/10.1093/cid/ciz406. · DOI
  29. [29]29. Nagel JL, Huang AM, Kunapuli A, Gandhi TN, Washer LL, Lassiter J, Patel T, Newton DW. 2014. Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 52:2849 -2854. https://doi.org/10 .1128/JCM.00682-14.
  30. [30]30. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM. 2014. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 69:216 -225. https://doi.org/10.1016/j.jinf.2014.05.005. · DOI
  31. [31]31. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. 2004. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis 38:1586 -1591. https://doi .org/10.1086/420936. · DOI · Paper page
  32. [32]32. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. 2016. The Third International Consensus De fi nitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:801 -810. https:// doi.org/10.1001/jama.2016.0287. · DOI · Paper page
  33. [33]33. Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens YE, Avondo A, Occelli C, Feral-Pierssens AL, Truchot J, Ortega M, Carneiro B, Pernet J, Claret PG, Dami F, Bloom B, Riou B, Beaune S, French Society of Emergency Medicine Collaborators Group. 2017. Prognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317:301 -308. https://doi.org/10.1001/jama.2016.20329. · DOI
  34. [34]34. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, Deutschman CS, Escobar GJ, Angus DC. 2016. Assessment of clinical criteria for sepsis: for the Third International Consensus De fi nitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:762 -774. https://doi.org/10.1001/jama.2016.0288. · DOI · Paper page
  35. [35]35. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, et al. 2017. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304 -377. https://doi.org/10.1007/s00134-017-4683-6. · DOI · Paper page
  36. [36]36. Ponderand L, Pavese P, Maubon D, Giraudon E, Girard T, Landelle C, Maurin M, Caspar Y. 2020. Evaluation of Rapid Sepsityper protocol and speci fi c MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS. Ann Clin Microbiol Antimicrob 19:60. https://doi.org/10.1186/s12941-020-00403-w. · DOI

Cited by

Sorted by citations

Authors
Babowicz, F., LaPlante, R., Mitchell, C., O’Donnell, J. N., Tobin, E., George, M., & Carreno, J. J.
Affiliations
  • Albany College of Pharmacy and Health Sciences (US)
  • Albany Medical Center Hospital (US)
  • Upstate Infectious Diseases Associates, Albany, New York, USA
Corresponding author
  • O’Donnell, J. Nicholas
  • Carreno, Joseph J.
ORCID
Venue
Antimicrobial Agents and Chemotherapy
Publisher
American Society for Microbiology
Published
2021-05-18
Volume
65
Issue
6
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
DOI
10.1128/aac.02364-20
PMC
PMC8315910
OpenAlex
W3137903049
Cited by
28
References
0
Citations by year
2026: 6 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 2
FWCI
2.81
Type
journal article
Language
en
Open access
Licence
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
Keywords
sepsis, gram-negative bacteremia, rapid molecular diagnostics, sepsis severity score, antibiotic use, length of hospital stay, clinical outcomes
MeSH terms
Blood Culture, Adolescent, Humans, Prospective Studies, Retrospective Studies, Bacteremia, Sepsis, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review